Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonia Moretti

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Journal of Clinical Medicine|October 13, 2021
Impact of Epithelial-Mesenchymal Immunophenotype on Local Aggressiveness in Papillary Thyroid Carcinoma Invading the AirwayMartina Mandarano, Marco Andolfi, Renato Colella, et al.
The Journal of Clinical Endocrinology and Metabolism|September 27, 2024
Wnt/B-catenin Activation and TP53 Mutations Associate With Distinct Immune Profiles in Advanced Thyroid CancerSonia Moretti, Martina Mandarano, Elisa Menicali, et al.
The Journal of Biological Chemistry|December 21, 2016
Signal Transducer and Activator of Transcription 1 Plays a Pivotal Role in RET/PTC3 Oncogene-induced Expression of Indoleamine 2,3-Dioxygenase 1Sonia Moretti, Elisa Menicali, Nicole Nucci, et al.
European Journal of Endocrinology|June 10, 2011
BRAF(V600E) mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomasCosimo Durante, Giovanni Tallini, Efisio Puxeddu, et al.
Cancer Research Communications|July 19, 2024
Clinical Efficacy of the HIV Protease Inhibitor Indinavir in Combination with Chemotherapy for Advanced Classic Kaposi Sarcoma Treatment: A Single-Arm, Phase II Trial in the ElderlyCecilia Sgadari, Biancamaria Scoppio, Orietta Picconi, et al.
Thyroid : Official Journal of the American Thyroid Association|February 12, 2009
Prohibitin is overexpressed in papillary thyroid carcinomas bearing the BRAF(V600E) mutationAlessandra Franzoni, Mariavittoria Dima, Maria D'Agostino, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 13, 2008
Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer propertiesAndrea Prodosmo, Simona Giglio, Sonia Moretti, et al.
Pathogens (Basel, Switzerland)|November 11, 2022
Clinical Impact of Colonization with Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Admitted for Severe TraumaGiancarlo Ceccarelli, Francesco Alessandri, Sonia Moretti, et al.
The Journal of Clinical Endocrinology and Metabolism|June 30, 2012
Modifications in the papillary thyroid cancer gene profile over the last 15 yearsCristina Romei, Laura Fugazzola, Efisio Puxeddu, et al.
Molecular Cancer Therapeutics|March 23, 2018
Anti-<i>hTERT</i> siRNA-Loaded Nanoparticles Block the Growth of Anaplastic Thyroid Cancer XenograftGiovanni E Lombardo, Valentina Maggisano, Marilena Celano, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Journal of Clinical Medicine|October 13, 2021
Impact of Epithelial-Mesenchymal Immunophenotype on Local Aggressiveness in Papillary Thyroid Carcinoma Invading the AirwayMartina Mandarano, Marco Andolfi, Renato Colella, et al.
The Journal of Clinical Endocrinology and Metabolism|September 27, 2024
Wnt/B-catenin Activation and TP53 Mutations Associate With Distinct Immune Profiles in Advanced Thyroid CancerSonia Moretti, Martina Mandarano, Elisa Menicali, et al.
The Journal of Biological Chemistry|December 21, 2016
Signal Transducer and Activator of Transcription 1 Plays a Pivotal Role in RET/PTC3 Oncogene-induced Expression of Indoleamine 2,3-Dioxygenase 1Sonia Moretti, Elisa Menicali, Nicole Nucci, et al.
European Journal of Endocrinology|June 10, 2011
BRAF(V600E) mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomasCosimo Durante, Giovanni Tallini, Efisio Puxeddu, et al.
Cancer Research Communications|July 19, 2024
Clinical Efficacy of the HIV Protease Inhibitor Indinavir in Combination with Chemotherapy for Advanced Classic Kaposi Sarcoma Treatment: A Single-Arm, Phase II Trial in the ElderlyCecilia Sgadari, Biancamaria Scoppio, Orietta Picconi, et al.
Thyroid : Official Journal of the American Thyroid Association|February 12, 2009
Prohibitin is overexpressed in papillary thyroid carcinomas bearing the BRAF(V600E) mutationAlessandra Franzoni, Mariavittoria Dima, Maria D'Agostino, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 13, 2008
Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer propertiesAndrea Prodosmo, Simona Giglio, Sonia Moretti, et al.
Pathogens (Basel, Switzerland)|November 11, 2022
Clinical Impact of Colonization with Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Admitted for Severe TraumaGiancarlo Ceccarelli, Francesco Alessandri, Sonia Moretti, et al.
The Journal of Clinical Endocrinology and Metabolism|June 30, 2012
Modifications in the papillary thyroid cancer gene profile over the last 15 yearsCristina Romei, Laura Fugazzola, Efisio Puxeddu, et al.
Molecular Cancer Therapeutics|March 23, 2018
Anti-<i>hTERT</i> siRNA-Loaded Nanoparticles Block the Growth of Anaplastic Thyroid Cancer XenograftGiovanni E Lombardo, Valentina Maggisano, Marilena Celano, et al.
Pageof 7